Pediatric Atopic Dermatitis Treatment Selection: Biologics vs Nonsteroidal Topical Therapies
October 14th 2025Experts discuss the recent FDA approval of topical JAK inhibitors for children 2 years or older as a promising advancement in pediatric atopic dermatitis treatment, highlighting their efficacy, their safety, and the practical challenges of integrating these options into individualized care plans while emphasizing the importance of patient education, access, and ongoing monitoring.
Navigating Available Topical Treatment Options for Pediatric Atopic Dermatitis
October 14th 2025Experts discuss the foundational role of topical therapies in pediatric atopic dermatitis management, highlighting the importance of individualized regimens that balance efficacy and safety, incorporate newer nonsteroidal options, and rely on patient education to overcome treatment hesitancy and support long-term disease control.
Pediatric Atopic Dermatitis Education: Lifestyle Modifications and Topical Therapy Management
October 7th 2025Experts discuss the central role of patient education and the strategic use of topical therapies in managing atopic dermatitis (AD), emphasizing the need for clear communication, age-appropriate guidance, and flexible treatment plans that leverage topicals for both short-term and long-term disease control.
Multidisciplinary Team Approach to Atopic Dermatitis: Diagnosis and Coordinated Care Strategies
October 7th 2025Experts discuss the importance of a multidisciplinary approach in managing pediatric atopic dermatitis (AD), highlighting the need for collaborative care, accurate diagnosis, psychosocial support, and long-term personalized strategies to address the disease’s complex physical and emotional burden.